Epipen 0.3mg Extended Use beyond labelled Expiry Date for Specific Lots

30-Sep-2019

25th September 2019 IMPORTANT UPDATE

Extended Use-by Period for Specific Lots of EpiPen® 0.3mg Adrenaline Auto-injectors


 

Extended use for specific lot numbers of EpiPen® 0.3mg Adrenaline Auto‐injectors.

This letter is sent in agreement with the UK medicines regulator, Medicines and Healthcare Products Regulatory Agency (MHRA), to inform you of the following:

Summary

Mylan UK have obtained acceptance from the MHRA to extend the use of specific lot numbers of EpiPen® 0.3mg auto‐injectors, by 4 months beyond the labelled expiry date.

The affected lot numbers are listed in the table below.

EpiPen® 0.3mg (single pack)

LOT

Labelled Expiry Date

 (end of the month)

Extended Use-by Date

(end of the month)

8FA092T

09/2019

01/2020

8FA273E

11/2019

03/2020

8KB332M

02/2020

06/2020

8FA366K

02/2020

06/2020

8FA367B

02/2020

06/2020

8KB478B

04/2020

08/2020

8KB474B

04/2020

08/2020

8KB481B

04/2020

08/2020

8KB510G

05/2020

09/2020

8KB523G

05/2020

09/2020

8KB648B

06/2020

10/2020

8KB587B

06/2020

10/2020

8KB630C

06/2020

10/2020

8KB587F

06/2020

10/2020

8KB671R

07/2020

11/2020

9KB087B

10/2020

02/2021

9KB148B

10/2020

02/2021

9KB177AE

11/2020

03/2021

9KB262B

12/2020

04/2021

EpiPen® 0.3mg (twin pack)

LOT

Labelled Expiry Date

(end of the month)

Extended Use-by Date

 (end of the month)

8KB558C

05/2020

09/2020

8KB630D

06/2020

10/2020

8KB671F

07/2020

11/2020

9KB148J

10/2020

02/2021

9KB177E

11/2020

03/2021

9KB252P

11/2020

03/2021

9KB301J

12/2020

04/2021

Important: the extended use only applies to the lots of EpiPen® 0.3mg auto-injectors listed above.  Patients can continue to use the EpiPen® 0.3mg auto-injectors of these specified lots safely until the extended use by date as stated above.

This extended use does not apply to EpiPen 0.15mg auto‐injectors or any lot number of EpiPen® 0.3mg auto-injectors not specified. Patients must continue to adhere to the labelled expiry date on any EpiPen not covered by the lot numbers above.

Further information on the extended use of the listed lots of EpiPen 0.3mg auto-injectors

There has been an interruption in the supply of adrenaline auto-injectors in the UK.  The overall market supply of adrenaline auto-injectors is being monitored by the Department of Health and Social Care.

To make sure patients can access their medicines during the supply shortage, the specific lots of EpiPen® 0.3mg auto-injectors (listed above) can be used 4 months beyond the labelled expiry date.

This 4-month extended use beyond the labelled expiry date for the specific lots listed above is based on supportive stability data for EpiPen® 0.3mg auto-injectors and has been reviewed by the MHRA.  The EpiPen® 0.3mg auto-injectors of these specific lots will continue to work safely and as intended within the extended use by date.  The EpiPen® auto-injectors should continue to be stored as labelled on the pack.

At the end of the extended use period (the end of the month listed under “Extended Use-by Date” in the table above), a new auto-injector will still need to be obtained.

Further information on recommendations to professional bodies and patient support groups

  • Tell patients and caregivers about the extended use-by date of the specified lots of EpiPen® 0.3mg auto-injectors as listed above.  This does not apply to other lots of EpiPen® 0.3mg auto-injectors and does not apply to any of EpiPen® 0.15mg auto-injectors.

  • Show patients and caregivers where to find the lot numbers on their device (on the end-flap of the box and if necessary, on the EpiPen® itself) and encourage them to sign up for the Expiry Alert Service.

  • Reassure patients and caregivers that their device will continue to work safely over the extended use period.

  • Remind patients and caregivers that they should still obtain a new device at the end of the extended use period.

Please continue to report any adverse events. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.

The information provided in this statement on the specific lot numbers listed above supersedes any other communication that patients may receive from the EpiPen® expiry alert service.

If you require additional information or have any questions, please contact,

Telephone: +44 (0)1707 853 000, Medical Information email: info@mylan.co.uk


Doctor

Become a BSACI Member...

GPs, Nurses, Allergy Specialists, Dieticians, Generalists

Join BSACI to receive the regular BSACI Allergy Update, have online access to the monthly journal 'Clinical & Experimental Allergy’, download our popular guidelines and a discount to the BSACI Annual Meeting.

Join Now